Cargando…
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
Prostate cancer (PCa) is the most common malignancy, and the third leading cancer-related cause of death among men of the Western world. Upon PCa progression into metastatic disease, androgen deprivation therapy is applied as the first-line treatment, and has been shown to be effective in most patie...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762760/ https://www.ncbi.nlm.nih.gov/pubmed/24009414 http://dx.doi.org/10.2147/DDDT.S45703 |